Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cyteir Therapeutics Inc.

    NASDAQ: CYT · Real-Time Price · USD
    3.02
    -0.07 (-2.27%)
    At close: Mar 15, 2024, 9:00 PM

    Cyteir Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -46.06M -42.13M
    Depreciation & Amortization
    		 668K 479K
    Stock-Based Compensation
    		 4.68M 3.46M
    Other Working Capital
    		 -1.87M 2.11M
    Other Non-Cash Items
    		 707K 4.42M
    Deferred Income Tax
    		 n/a -4.42M
    Change in Working Capital
    		 -2.53M 2.15M
    Operating Cash Flow
    		 -42.53M -36.03M
    Capital Expenditures
    		 -312K -1.19M
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 -312K -1.19M
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 242K 216.01M
    Financial Cash Flow
    		 242K 216.01K
    Net Cash Flow
    		 -42.6M 178.78M
    Free Cash Flow
    		 -42.84M -37.22M

    Add to Watchlist